Crohn-betegség: vizsgálatok itt: Japán

In Japán 22 Also abroad 422

22 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

3. fázisTaking people
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Where
Abiko, Bunkyō, Chūō, Fukuoka, Fukuyama, Ginowan, Hamamatsu, Hirakata, Hiroshima, Hitachi, Kagoshima, Kamakura, Kanazawa, Kashiwa, Kawagoe, Kawasaki, Kofu, Kumamoto, Kurume, Kyoto, Maebashi, Minato, Minato-ku, Mitaka, Mitato, Nagakute, Nagoya, Nishinomiya, Okayama, Osaka, Saga, Sakura, Sapporo, Sendai, Shimizu, Shinjuku, Shiwa-gun, Tokyo, Toyama, Tsu, Tsuchiura, Tsukuba, Yamagata, Yokohama
Életkor
16 év to 80 év
People
1200 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06430801 · EU 2023-508636-61-00
2. fázisTaking people
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Where
Asahikawa, Bunkyō, Chikushino-shi, Kashiwa-shi, Kobe, Kofu, Nagasaki, Nara, Osaka, Saga, Saitama, Saitama-Ken, Sakura, Sapporo, Tokyo
Életkor
18 év to 85 év
People
385 worldwide
Run by
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
See details and how to joinNCT06226883 · EU 2023-508158-24-00
3. fázisTaking people
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Where
Hirosaki, Kagoshima, Kashiwa-shi, Kobe, Saga, Sendai, Setagaya-Ku, Tokyo, Tsu, Ube, Yokohama
Életkor
2 év to 17 év
People
120 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT05923073 · EU 2023-504735-41-00
3. fázisTaking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Fuchū, Kanazawa, Kobe, Kumamoto, Matsumoto, Saga, Yokohama
Életkor
3 év to 64 év
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
2/3. fázisTaking people
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Where
Chiba, Fukui-shi, Gamagōri, Hamamatsu, Higashiibaraki-gun, Hiroshima, Kagawa, Kagoshima, Kanazawa, Kashiwa, Kawagoe, Kitakyushu, Kumamoto, Kurume, Mitaka, Miyagi, Nagakute, Nagasaki, Nishinomiya-shi, Okinawa, Osaka, Saga, Sakura, Sapporo, Sendai, Shinjuku-ku, Shinjuku-Ku, Sunto-gun
Életkor
18 év and over
People
1092 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07196722 · EU 2025-521382-27-00
3. fázisTaking people
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Where
Bunkyō City, Hamamatsu, Hirosaki, Kagoshima, Kashiwa, Kobe, Kumamoto, Minatoku, Mitaka, Nagoya, Nishinomiya, Osaka, Sapporo, Sendai, Shimizu, Takamatsu, Tokyo, Yamanashi, Yokohama
Életkor
18 év and over
People
460 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07577843 · EU 2026-525922-39-00
2. fázisTaking people
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Where
Chiba, Fukuoka, Hamamatsu, Hirakata, Minato, Mitaka, Morioka, Nishinomiya, Sapporo, Sendai, Takatsuki-shi, Tokyo, Toyama
Életkor
18 év to 75 év
People
268 worldwide
Run by
Takeda
See details and how to joinNCT06233461 · EU 2023-506704-14-00
2. fázisTaking people
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Where
Bunkyō City, Hamamatsu, Hirosaki, Kashiwa, Morioka, Nishinomiya, Ōita
Életkor
18 év to 75 év
People
99 worldwide
Run by
Sanofi
See details and how to joinNCT06958536 · EU 2024-517016-30-00
2. fázisTaking people
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Where
Kure
Életkor
18 év to 75 év
People
2000 worldwide
Run by
AbbVie
See details and how to joinNCT07697456 · EU 2026-525959-86-00
4. fázisTaking people
Risankizumab for Refractory Perianal Fistulizing Crohn's Disease
Where
Nishinomiya, Shinjuku-Ku, Yokohama
Életkor
15 év and over
People
25
Run by
Yuki Horio
See details and how to joinNCT07872449
3. fázisTaking people
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Where
Asahikawa, Bunkyō City, Chikushino-shi, Fukuoka, Hachiōji, Isehara, Isesaki, Kagoshima, Kamakura, Kashiwa, Kitakyushu, Kobe, Kōriyama, Kumamoto, Kurume, Maebashi, Minato, Mitaka, Nagakute, Nagoya, Nishinomiya, Okayama, Osaka, Saga, Sagamihara, Sakura, Sapporo, Sendai, Shimotsuga-gun, Shinjuku, Shiwa-gun, Shizuoka, Toyama, Toyohashi, Tsu, Yokohama
Életkor
16 év to 80 év
People
980 worldwide
Run by
Sanofi
See details and how to joinNCT07184931
3. fázisTaking people
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Where
Kamakura, Nishinomiya, Tsu
Életkor
16 év to 80 év
People
751 worldwide
Run by
Sanofi
See details and how to joinNCT07184944
3. fázisTaking people
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Where
Bunkyo-ku, Fuchu-shi, Izumi-Shi, Kashiwa-shi, Kumamoto, Kurume-shi, Maebashi, Ōbu, Saitama-shi, Setagaya City
Életkor
2 év to 17 év
People
110 worldwide
Run by
AbbVie
See details and how to joinNCT05995353 · EU 2022-502050-14-00
3. fázisTaking people
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Where
Aichi, Aomori, Asahikawa-shi, Asahikawa-Shi, Chiba, Chikushino-shi, Ehime, Fukui, Fukuoka, Hiroshima, Hokkaido, Hyōgo, Ishikawa, Kagawa, Kagoshima, Kanagawa, Kumamoto, Miyagi, Nagasaki, Okayama, Osaka, Saga, Sendai, Shizuoka, Takamatsu, Tokyo, Toyama, Wakayama, Yamagata, Yamanashi
Életkor
16 év to 80 év
People
600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06819878 · EU 2024-513053-69-00
3. fázisTaking people
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Bunkyo-ku, Kurume-shi, Setagaya-Ku
Életkor
2 év to 17 év
People
70 worldwide
Run by
Takeda
See details and how to joinNCT06405087 · EU 2023-508804-39-00
3. fázisTaking people
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Where
Bunkyō, Bunkyō City, Kashiwa, Kobe, Tokyo, Yokohama
Életkor
2 év to 19 év
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT04844606
3. fázisTaking people
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Where
Bunkyō City, Hirosaki, Kagoshima, Kashiwa-shi, Kobe, Saga, Sendai, Setagaya-Ku, Tsu, Ube, Yokohama
Életkor
2 év to 17 év
People
90 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT05509777 · EU 2024-511472-32-00
3. fázisTaking people
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Where
Bunkyo-ku, Kurume, Setagaya-Ku
Életkor
2 év to 17 év
People
70 worldwide
Run by
Takeda
See details and how to joinNCT06100289 · EU 2023-503188-40-00
3. fázisTaking people
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Bunkyo-ku, Hidaka, Kumamoto, Kurume-shi, Setagaya-Ku
Életkor
2 év to 17 év
People
240 worldwide
Run by
Takeda
See details and how to joinNCT05442567 · EU 2023-509046-36-00
3. fázisTaking people
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Where
Bunkyo-ku, Kumamoto, Kurume-shi, Setagaya-Ku
Életkor
2 év to 17 év
People
120 worldwide
Run by
Takeda
See details and how to joinNCT04779320 · EU 2023-509045-13-00
No phaseTaking people
An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan
Where
Ageo, Ako, Anjo-shi, Bunkyo-ku, Chikushino-shi, Chuo-ku, Fukui, Fukuoka, Fukushima, Fukuyama-shi, Gifu, Ginowan-shi, Hachinohe, Hamamatsu, Handa, Hatsukaichi, Himeji, Himeji-shi, Hiroshima, Ibaraki-shi, Isehara, Itami, Kagoshima, Kakamigahara-shi, Kamakura-shi, Kanazawa, Kashiwa-shi, Kawagoe, Kitakyushu, Kitakyushu-shi, Kobe, Kochi, Kofu, Koganei-shi, Kōriyama, Kumamoto, Kurume, Kurume-shi, Kyoto, Matsuyama, Mibu, Minato-ku, Moriguchi, Nagakute, Nagano, Nagasaki, Nagoya, Naha, Nishinomiya-shi, Odawara-shi, Ōita, Onga-gun, Ono, Osaka, Saga, Sagamihara-shi, Saitama, Saitama-shi, Sakai, Sapporo, Setagaya-ku, Shibuya-ku, Shinjuku-ku, Shizuoka, Sizuoka-shi, Sumida-ku, Sunto-gun, Takamatsu, Takatsuki, Tokorozawa, Tokyo, Toyama, Toyohashi, Toyonaka, Toyota-shi, Tsu, Tsukuba, Ube, Utsunomiya, Uwajima, Wakayama, Yamagata, Yamaguchi, Yokkaichi-shi, Yokohama
Életkor
15 év and over
People
240
Run by
AbbVie
See details and how to joinNCT06023030
No phaseTaking people
A Survey of Darvadstrocel in People With Crohn's Disease
Where
Tokyo
Életkor
20 év and over
People
275
Run by
Takeda
See details and how to joinNCT05113095